SNAI2 and glioblastoma: Hongbo Guo et al. found that miR-203 expressed low in imatinib-resistant GBM cells(U87AR,U251AR), and ectopic expression of miR-203 obviously reversed EMT by directly targeting SNAI2,which sensitized glioma cells to chemotherapy [41].